Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Non-Current Deffered Revenue (2023 - 2024)

Historic Non-Current Deffered Revenue for Lifecore Biomedical, Inc. \De\ (LFCR) over the last 3 years, with Q4 2024 value amounting to $4.9 million.

  • Lifecore Biomedical, Inc. \De\'s Non-Current Deffered Revenue rose 142024.92% to $4.9 million in Q4 2024 from the same period last year, while for Nov 2024 it was $4.9 million, marking a year-over-year increase of 142024.92%. This contributed to the annual value of $4.7 million for FY2024, which is 5996.6% up from last year.
  • Per Lifecore Biomedical, Inc. \De\'s latest filing, its Non-Current Deffered Revenue stood at $4.9 million for Q4 2024, which was up 142024.92% from $4.8 million recorded in Q3 2024.
  • In the past 5 years, Lifecore Biomedical, Inc. \De\'s Non-Current Deffered Revenue ranged from a high of $4.9 million in Q4 2024 and a low of $321000.0 during Q4 2023